By Sterling Pharma Solutions

Complex and targeted therapies are dominating the drug development pipeline and the increasing complexity of the chemical entities involved in producing these drugs is driving the demand for hazardous chemical manufacturing services.

As a result, API manufacturers need to take steps to ensure worker safety and minimise the environmental impact associated with handling hazardous chemistry. Effective and thorough hazard evaluation plays a critical role in this process.

In an article published in Manufacturing Chemist, our Process Engineering Manager, Paul Moscrop, discusses the current trend for hazardous chemistry in the API manufacturing space. He also explores the importance of integrating process engineering and chemistry expertise to ensure project success. Read the full article here: